Article Details

NMPA approves AstraZeneca's Fasenra for severe asthma - Yahoo Finance

Retrieved on: 2024-08-21 21:47:43

Tags for this article:

Click the tags to see associated articles and topics

NMPA approves AstraZeneca's Fasenra for severe asthma - Yahoo Finance. View article details on hiswai:

Excerpt

The China National Medical Products Association (NMPA) has approved AstraZeneca's Fasenra (benralizumab) as a maintenance treatment for ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up